Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It was originally investigated for the treatment of Alzheimers disease and Parkinsons disease, and was subsequently dropped from development for these applications after early trial results showed limited efficacy for treatment of these diseases
Reconstitute: add 3 mL of bacteriostatic water to the 600 mg vial
Recommended articles Optimising GLP-1RA Efficacy: A Meta-Analysis of Baseline Age and HbA1c as Predictors of MACE Reduction in T2DM Ghosal S, Ghosal A Diabetes, Metabolic Syndrome and Obesity 2025, 18:4347-4358 Published Date: 26 November 2025 Real-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study Hwang I, Lee SW, Kim Y Drug Design, Development and Therapy 2026, 20:604247 Published Date: 14 July 2026
These findings have made the peptide relevant for laboratory work focused on energy storage, fat redistribution, and endocrine control of metabolic flux across tissues [1][2][5]
US$ 24.83
US$ 29.77
US$ 26.76
US$ 20.05
US$ 29.53
US$ 20.86
